Jan 30, 2026
1:12
For every 12 shares held, investors received 1. The price per share adjusted from $1.26 to $15.12.
The split itself did not change the total investment value.
Satellos Bioscience Inc (TSX:MSCL) operates in the Pharmaceuticals: major industry.
Satellos Bioscience Inc company overviewSatellos Bioscience Inc's most recent stock split was on January 30, 2026. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
Satellos Bioscience Inc (TSX:MSCL) has split its stock 3 times: a 5-for-14 reverse split on January 7, 2008, a 1-for-20 reverse split on August 18, 2021, and a 1-for-12 reverse split on January 30, 2026.
Satellos Bioscience Inc has split its stock 3 times. This history records 3 reverse splits between January 7, 2008 and January 30, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Satellos Bioscience Inc's 1-for-12 reverse split on January 30, 2026, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Satellos Bioscience Inc has not announced a new split in our records. Its most recent split was on January 30, 2026, less than a year ago. Companies announce splits in advance, and any new TSX:MSCL split will appear on this page.
Already premium?